MLchartDataset catalogue

TAC-101

Term · Oncology and biomedicine · MLC-T-ONC-008484

A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called synthetic retinoids and angiogenesis inhibitors.

Table 1. Record
IdentifierMLC-T-ONC-008484
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-008484",
  "term": "TAC-101",
  "field": "Oncology and biomedicine",
  "definition": "A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called synthetic retinoids and angiogenesis inhibitors.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tac-101/"
}

Record 15,931 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.